S 2729
115th Congress
Senate
Health
Alternative treatments
Business ethics
Business records
Congressional oversight
Drug safety, medical device, and laboratory regulation
Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Government information and archives
Government studies and investigations
Health care quality
Health information and medical records
Health personnel
Health programs administration and funding
Health promotion and preventive care
Health technology, devices, supplies
Hospital care
Indian social and development programs
Licensing and registrations
Addiction Prevention and Responsible Opioid Practices Act
Introduced: April 23, 2018
Introduced by:
Durbin, Richard J.
Democratic
· Illinois
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 23, 2018
Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S2343-2346)
Apr 23, 2018
Introduced in Senate
Plain-English summary
Addiction Prevention and Responsible Opioid Practices Act
This bill establishes a series of requirements relating to opioid regulation, prescribing, and monitoring, including licensure requirements for pharmaceutical representatives, a national opioid drug mapping tool to monitor prescribing practices of Medicaid providers, and an excise tax on opioid manufacturers.
What's happening now
Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S2343-2346)
Committees of jurisdiction
1